Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias

Pediatric Blood & Cancer
Nirali N ShahAlan S Wayne

Abstract

Vincristine sulfate liposome injection (VSLI; Marqibo®) is an encapsulated preparation of standard vincristine in sphingomyelin/cholesterol liposomes. Clinical trials in adults have demonstrated safety, tolerability, and activity, leading to Food and Drug Administration (FDA) approval for adults with relapsed acute lymphoblastic leukemia (ALL). Pediatric experience with VSLI is limited. This single center, phase I dose escalation study examined the safety, toxicity, maximum tolerated dose, and pharmacokinetics of VSLI administered weekly to pediatric patients age <21 years with relapsed or chemotherapy-refractory solid tumors or leukemia. Twenty-one subjects were treated in total. Median age was 13.3 years (range 2-19). Fourteen subjects completed one 28-day cycle of therapy and five subjects completed more than one cycle. No subject experienced dose-limiting toxicity (DLT) at the first dose level (1.75 mg/m(2) /dose, dose range: 2-3.7 mg). At the second dose level (2.25 mg/m(2) /dose, dose range: 1.3-4.5 mg), one subject had transient dose-limiting grade 4 transaminase elevation, and this dose level was expanded with no additional DLT observed. The second dose level then opened to an expansion phase to evaluate activity in ALL...Continue Reading

References

May 5, 1973·Lancet
Jan 1, 1981·Cancer Chemotherapy and Pharmacology·V S Sethi, J C Kimball
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ellis GroningerSiebold de Graaf
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey M SkolnikPeter C Adamson
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Dec 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ching-Hon PuiMary V Relling
Oct 24, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard B WomerAaron R Weiss
Nov 22, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan O'BrienHagop Kantarjian
Dec 6, 2012·Cancer Chemotherapy and Pharmacology·Jeffrey A Silverman, Steven R Deitcher
Feb 21, 2013·Pediatric Blood & Cancer·David R FreyerUNKNOWN COG Adolescent and Young Adult Oncology Discipline Committee

❮ Previous
Next ❯

Citations

Jul 28, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Andra-Sorina TatarSimion Astilean
Nov 12, 2016·Therapeutic Delivery·Mariacristina Gagliardi
Mar 19, 2019·Current Hematologic Malignancy Reports·Christine M McMahon, Selina M Luger
Jun 21, 2017·Journal of Translational Medicine·Michele GraciottiLana Kandalaft
Jan 25, 2020·American Journal of Clinical Oncology·Osama M Al-Quteimat
Dec 13, 2017·Clinical and Translational Medicine·Stephanie TranPrakash Rai
Feb 1, 2020·Recent Patents on Anti-cancer Drug Discovery·Hongyu TaoXiukun Lin
Apr 19, 2017·British Journal of Haematology·Claire A McClainEric S Schafer
Sep 19, 2019·Expert Opinion on Drug Delivery·Ludger M Ickenstein, Patrick Garidel
Feb 12, 2020·Nanomaterials·Mohammad HoushmandClaudia Giachino
Jan 13, 2018·Frontiers in Bioengineering and Biotechnology·Raquel VinhasPedro V Baptista
Jun 27, 2020·Blood·Stephen P Hunger, Elizabeth A Raetz
Nov 4, 2017·Cancer Research·Christopher C MillsValerie B Sampson
Sep 9, 2019·Advanced Drug Delivery Reviews·Venkata K YellepeddiElizabeth Nance
Oct 7, 2019·Drug Discovery Today·Mohammad NorouziFatemeh Atyabi
Nov 28, 2020·International Journal of Nanomedicine·Madhusmita Dhupal, Devasish Chowdhury
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zahra PayandehSaeed Khalil
Jun 3, 2021·Pharmaceutics·Noelia Nieto GonzálezElisabetta Gavini
Aug 3, 2018·ACS Nano·Carlos Rodríguez-NogalesMaría J Blanco-Prieto
Dec 17, 2021·Biomacromolecules·Yifan ZhangZhiyuan Zhong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.